PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO.JK)
IDR 545.0
(-2.68%)
IDR 545.0
(-2.68%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3565.93 Billion IDR | -7.75% |
| 2022 | 3865.52 Billion IDR | -3.87% |
| 2021 | 4020.98 Billion IDR | 20.55% |
| 2020 | 3335.41 Billion IDR | 8.74% |
| 2019 | 3067.43 Billion IDR | 11.01% |
| 2018 | 2763.29 Billion IDR | 7.36% |
| 2017 | 2573.84 Billion IDR | 0.47% |
| 2016 | 2561.8 Billion IDR | 15.47% |
| 2015 | 2218.53 Billion IDR | 0.94% |
| 2014 | 2197.9 Billion IDR | -7.35% |
| 2013 | 2372.36 Billion IDR | -0.81% |
| 2012 | 2391.66 Billion IDR | 8.8% |
| 2011 | 2198.27 Billion IDR | 17.77% |
| 2010 | 1866.53 Billion IDR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 730.2 Billion IDR | -13.39% |
| 2024 Q1 | 1053.42 Billion IDR | -12.55% |
| 2024 Q2 | 843.06 Billion IDR | -19.97% |
| 2023 FY | 3565.93 Billion IDR | -7.75% |
| 2023 Q1 | 907.3 Billion IDR | -27.52% |
| 2023 Q2 | 746.49 Billion IDR | -17.72% |
| 2023 Q4 | 1204.63 Billion IDR | 70.26% |
| 2023 Q3 | 707.5 Billion IDR | -5.22% |
| 2022 Q3 | 1001.67 Billion IDR | 36.91% |
| 2022 Q1 | 880.49 Billion IDR | -29.25% |
| 2022 FY | 3865.52 Billion IDR | -3.87% |
| 2022 Q4 | 1251.74 Billion IDR | 24.97% |
| 2022 Q2 | 731.6 Billion IDR | -16.91% |
| 2021 Q4 | 1244.54 Billion IDR | 10.96% |
| 2021 Q1 | 793.41 Billion IDR | -26.41% |
| 2021 Q2 | 861.38 Billion IDR | 8.57% |
| 2021 Q3 | 1121.64 Billion IDR | 30.21% |
| 2021 FY | 4020.98 Billion IDR | 20.55% |
| 2020 Q1 | 730.71 Billion IDR | -22.17% |
| 2020 Q3 | 797.56 Billion IDR | 9.41% |
| 2020 Q2 | 728.99 Billion IDR | -0.24% |
| 2020 FY | 3335.41 Billion IDR | 8.74% |
| 2020 Q4 | 1078.13 Billion IDR | 35.18% |
| 2019 Q1 | 713.67 Billion IDR | -12.87% |
| 2019 Q4 | 938.82 Billion IDR | 30.66% |
| 2019 Q3 | 718.52 Billion IDR | 3.18% |
| 2019 Q2 | 696.4 Billion IDR | -2.42% |
| 2019 FY | 3067.43 Billion IDR | 11.01% |
| 2018 Q3 | 669.93 Billion IDR | 2.52% |
| 2018 FY | 2763.29 Billion IDR | 7.36% |
| 2018 Q4 | 819.06 Billion IDR | 22.26% |
| 2018 Q2 | 653.44 Billion IDR | 5.25% |
| 2018 Q1 | 620.84 Billion IDR | -13.33% |
| 2017 Q2 | 605.7 Billion IDR | 0.37% |
| 2017 Q4 | 716.35 Billion IDR | 10.5% |
| 2017 FY | 2573.84 Billion IDR | 0.47% |
| 2017 Q1 | 603.48 Billion IDR | -9.99% |
| 2017 Q3 | 648.29 Billion IDR | 7.03% |
| 2016 Q3 | 594.02 Billion IDR | -13.79% |
| 2016 Q4 | 670.45 Billion IDR | 12.87% |
| 2016 Q2 | 689.08 Billion IDR | 13.29% |
| 2016 FY | 2561.8 Billion IDR | 15.47% |
| 2016 Q1 | 608.24 Billion IDR | 7.04% |
| 2015 Q1 | 509.41 Billion IDR | -15.65% |
| 2015 Q3 | 509.2 Billion IDR | -19.39% |
| 2015 Q2 | 631.69 Billion IDR | 24.0% |
| 2015 FY | 2218.53 Billion IDR | 0.94% |
| 2015 Q4 | 568.22 Billion IDR | 11.59% |
| 2014 Q1 | 520.02 Billion IDR | -17.39% |
| 2014 Q3 | 474.44 Billion IDR | -20.86% |
| 2014 Q2 | 599.49 Billion IDR | 15.28% |
| 2014 Q4 | 603.93 Billion IDR | 27.29% |
| 2014 FY | 2197.9 Billion IDR | -7.35% |
| 2013 Q4 | 629.51 Billion IDR | 4.18% |
| 2013 FY | 2372.36 Billion IDR | -0.81% |
| 2013 Q2 | 574.92 Billion IDR | 2.0% |
| 2013 Q3 | 604.27 Billion IDR | 5.1% |
| 2013 Q1 | 563.64 Billion IDR | 0.0% |
| 2012 FY | 2391.66 Billion IDR | 8.8% |
| 2011 FY | 2198.27 Billion IDR | 17.77% |
| 2010 FY | 1866.53 Billion IDR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 1890.88 Billion IDR | -88.585% |
| PT Merck Tbk | 961.43 Billion IDR | -270.897% |
| PT Phapros, Tbk | 1014.12 Billion IDR | -251.625% |
| PT Pyridam Farma Tbk | 702.06 Billion IDR | -407.918% |
| PT Tempo Scan Pacific Tbk | 13119.78 Billion IDR | 72.82% |